Table 1.

Patient characteristics (n = 118)

Characteristic	Value
Age
Median	49
Range	30–84
Menopausal Status
Premenopausal	80 (68%)
Postmenopausal	38 (32%)
Histologic Type
Ductal Carcinoma	100 (84.7%)
Lobular Carcinoma	6 (5.1%)
Unclassified	12 (10.2%)
Clinical Primary Tumor
T1	19 (16.1%)
T2	19 (16.1%)
T3	74 (62.7%)
T4	6 (5.1%)
Chemotherapeutic Regimens*
DEC	58 (49.2%)
EFC	37 (31.4%)
VFC	23 (19.5%)

* D docetaxel, E epirubicin, C cyclophosphamide, F 5-Fluorouracil, V vinorelbine or vincristine